Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia.
暂无分享,去创建一个
[1] S. Anker,et al. Impact of levosimendan treatment on chronic heart failure. , 2004, The American journal of cardiology.
[2] J. Eha,et al. Pharmacodynamics and Pharmacokinetics of Oral Levosimendan and Its Metabolites in Patients With Severe Congestive Heart Failure: A Dosing Interval Study , 2004, Journal of clinical pharmacology.
[3] S. Adamopoulos,et al. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. , 2004, The American journal of cardiology.
[4] P. Pentikäinen,et al. Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure , 2002, Journal of clinical pharmacology.